文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期,新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

Comparison of the immune profile of nonhealing cutaneous Leishmaniasis patients with those with active lesions and those who have recovered from infection.

作者信息

Ajdary S, Alimohammadian M H, Eslami M B, Kemp K, Kharazmi A

机构信息

Department of Immunology, Pasteur Institute, Tehran, Iran.

出版信息

Infect Immun. 2000 Apr;68(4):1760-4. doi: 10.1128/IAI.68.4.1760-1764.2000.


DOI:10.1128/IAI.68.4.1760-1764.2000
PMID:10722561
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC97345/
Abstract

Th1-type cellular immune responses play a critical role in protection against infection with Leishmania parasites, whereas activation of Th2-type cells results in progressive disease. Cutaneous leishmaniasis caused by Leishmania major is often a self-healing disease; however, persistent nonhealing forms are also known. In the present study, we have described cell-mediated immune responses in nonhealing patients by measuring T-cell proliferation, cytokine production, and phenotypic characterization of these cells. The responses were compared with those of patients with active lesions, patients who had recovered from infection, and healthy controls. Peripheral blood mononuclear cells from patients with active lesions and recovered donors proliferated vigorously and produced Th1-type cytokine when stimulated with L. major antigens, whereas in nonhealing patients the proliferative responses were significantly lower and showed a Th2-type response to Leishmania antigens. Interleukin-10 (IL-10) production was not a feature of L. major stimulation. Flow cytometric analysis revealed that L. major antigen induced proliferation of the CD4-positive population and that these cells were the major source of gamma interferon and IL-4. These results show a distinct dichotomy in the cytokine response to L. major infection.

摘要

相似文献

[1]
Comparison of the immune profile of nonhealing cutaneous Leishmaniasis patients with those with active lesions and those who have recovered from infection.

Infect Immun. 2000-4

[2]
The Leishmania promastigote surface antigen-2 (PSA-2) is specifically recognised by Th1 cells in humans with naturally acquired immunity to L. major.

FEMS Immunol Med Microbiol. 1998-3

[3]
Dichotomy of the human T cell response to Leishmania antigens. I. Th1-like response to Leishmania major promastigote antigens in individuals recovered from cutaneous leishmaniasis.

Clin Exp Immunol. 1994-6

[4]
A recombinant Leishmania antigen that stimulates human peripheral blood mononuclear cells to express a Th1-type cytokine profile and to produce interleukin 12.

J Exp Med. 1995-4-1

[5]
Nonhealing infection despite Th1 polarization produced by a strain of Leishmania major in C57BL/6 mice.

J Immunol. 2005-3-1

[6]
Flow cytometric determination of cellular sources and frequencies of key cytokine-producing lymphocytes directed against recombinant LACK and soluble Leishmania antigen in human cutaneous leishmaniasis.

Infect Immun. 2001-5

[7]
Phenotypic and Functional Profiles of Antigen-Specific CD4 and CD8 T Cells Associated With Infection Control in Patients With Cutaneous Leishmaniasis.

Front Cell Infect Microbiol. 2018-11-19

[8]
T-cell responsiveness of American cutaneous leishmaniasis patients to purified Leishmania pifanoi amastigote antigens and Leishmania braziliensis promastigote antigens: immunologic patterns associated with cure.

Exp Parasitol. 1996-11

[9]
Regulatory interactions between CD45RBhigh and CD45RBlow CD4+ T cells are important for the balance between protective and pathogenic cell-mediated immunity.

J Exp Med. 1994-2-1

[10]
Deletion of IL-4Ralpha on CD4 T cells renders BALB/c mice resistant to Leishmania major infection.

PLoS Pathog. 2007-5-11

引用本文的文献

[1]
Impact of co-infection with Plasmodium berghei ANKA in Leishmania major-parasitized mice on immune modulation and cutaneous leishmaniasis.

PLoS Negl Trop Dis. 2025-7-28

[2]
Safety and reactogenicity of a controlled human infection model of sand fly-transmitted cutaneous leishmaniasis.

Nat Med. 2024-11

[3]
A Prospective cohort study of zoonotic cutaneous leishmaniasis in tunisia: Clinical and Immunological features and immune correlates of protection.

PLoS Negl Trop Dis. 2023-12

[4]
Therapeutic Activity of a Topical Formulation Containing 8-Hydroxyquinoline for Cutaneous Leishmaniasis.

Pharmaceutics. 2023-11-8

[5]
A Historic Review of the Role of CD4+ T-Cell Subsets in Development of the Immune Responses against Cutaneous and Visceral Leishmaniases.

Iran Biomed J. 2022-3-1

[6]
An Insight Into Systemic Immune Response in Mediated Atypical Cutaneous Leishmaniasis in the New Endemic State of Himachal Pradesh, India.

Front Immunol. 2021

[7]
Variation in Leishmania chemokine suppression driven by diversification of the GP63 virulence factor.

PLoS Negl Trop Dis. 2021-10

[8]
The Comparison of the IFN-ɤ, TNF-α and IL-10 Cytokines in Healing and Non-healing Cutaneous Leishmaniasis.

Iran J Parasitol. 2021

[9]
Identification and Characterization of the miRNAs and Cytokines in Response to Leishmania infantum Infection with Different Response to Treatment.

Acta Parasitol. 2022-3

[10]
Immune Responses in Cutaneous Leishmaniasis: Thelper1/Thelper2 Cytokine Profiles Using Live Versus Killed .

J Arthropod Borne Dis. 2021-3-31

本文引用的文献

[1]
Interferon-gamma- and tumour necrosis factor-alpha-producing cells in humans who are immune to cutaneous leishmaniasis.

Scand J Immunol. 1999-6

[2]
Regulation of protective immunity against Leishmania major in mice.

Curr Opin Immunol. 1998-8

[3]
Immunologic determinants of disease evolution in localized cutaneous leishmaniasis due to Leishmania major.

J Infect Dis. 1998-6

[4]
Indications of the protective role of natural killer cells in human cutaneous leishmaniasis in an area of endemicity.

Infect Immun. 1998-6

[5]
The Leishmania promastigote surface antigen-2 (PSA-2) is specifically recognised by Th1 cells in humans with naturally acquired immunity to L. major.

FEMS Immunol Med Microbiol. 1998-3

[6]
High levels of plasma IL-10 and expression of IL-10 by keratinocytes during visceral leishmaniasis predict subsequent development of post-kala-azar dermal leishmaniasis.

Clin Exp Immunol. 1998-1

[7]
Interferon-gamma production by human T cells and natural killer cells in vitro in response to antigens from the two intracellular pathogens Mycobacterium tuberculosis and Leishmania major.

Scand J Immunol. 1997-11

[8]
Biochemical analysis and immunogenicity of Leishmania major amastigote fractions in cutaneous leishmaniasis.

Clin Exp Immunol. 1997-11

[9]
Epidemiological study of reservoir hosts in an endemic area of zoonotic cutaneous leishmaniasis in Iran.

Bull World Health Organ. 1996

[10]
T-cell responsiveness of American cutaneous leishmaniasis patients to purified Leishmania pifanoi amastigote antigens and Leishmania braziliensis promastigote antigens: immunologic patterns associated with cure.

Exp Parasitol. 1996-11

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索